Medifast Inc
NYSE:MED

Watchlist Manager
Medifast Inc Logo
Medifast Inc
NYSE:MED
Watchlist
Price: 17.825 USD -1.74%
Market Cap: 195m USD
Have any thoughts about
Medifast Inc?
Write Note

Medifast Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medifast Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Medifast Inc
NYSE:MED
Research & Development
-$4.4m
CAGR 3-Years
-2%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Estee Lauder Companies Inc
NYSE:EL
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bellring Brands Inc
NYSE:BRBR
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Coty Inc
NYSE:COTY
Research & Development
-$126.8m
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Inter Parfums Inc
NASDAQ:IPAR
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
elf Beauty Inc
NYSE:ELF
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medifast Inc
Glance View

Market Cap
195m USD
Industry
Consumer products

Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

MED Intrinsic Value
20.53 USD
Undervaluation 13%
Intrinsic Value
Price

See Also

What is Medifast Inc's Research & Development?
Research & Development
-4.4m USD

Based on the financial report for Sep 30, 2024, Medifast Inc's Research & Development amounts to -4.4m USD.

What is Medifast Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-20%

Over the last year, the Research & Development growth was 4%. The average annual Research & Development growth rates for Medifast Inc have been -2% over the past three years , -20% over the past five years .

Back to Top